(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(4-(4-(6-methoxypyridin-3-yl)phenyl)piperazin-1-yl)-9H-purin-9-yl)tetrahydrofuran-3,4-diol

ID: ALA4475059

PubChem CID: 155537423

Max Phase: Preclinical

Molecular Formula: C26H29N7O5

Molecular Weight: 519.56

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2ccc(N3CCN(c4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)CC3)cc2)cn1

Standard InChI:  InChI=1S/C26H29N7O5/c1-37-20-7-4-17(12-27-20)16-2-5-18(6-3-16)31-8-10-32(11-9-31)24-21-25(29-14-28-24)33(15-30-21)26-23(36)22(35)19(13-34)38-26/h2-7,12,14-15,19,22-23,26,34-36H,8-11,13H2,1H3/t19-,22-,23-,26-/m1/s1

Standard InChI Key:  KPLOKPNBAAPEML-VJUOEERUSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   24.4157  -11.3334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.4262  -10.0100    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.9433  -10.6681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2036  -10.2701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1904  -11.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8915  -11.5117    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.6103  -11.1146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6235  -10.2929    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.9179   -9.8683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9300   -9.0512    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.6506   -8.6549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6645   -7.8414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9647   -7.4186    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.2493   -7.8155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2336   -8.6351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1529  -12.1111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3730  -12.3548    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.3637  -13.1720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1381  -13.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6257  -12.7776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4429  -12.7868    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.3818  -14.2133    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.6972  -13.6448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9545  -13.3040    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.9781   -6.6029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6949   -6.2081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7103   -5.3918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0098   -4.9694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2922   -5.3691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2803   -6.1841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0250   -4.1551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7412   -3.7593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7555   -2.9430    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.0544   -2.5215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3374   -2.9222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3265   -3.7373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0674   -1.7044    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.7814   -1.3071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  4  2  1  0
  2  3  2  0
  3  1  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 16  1  0
 16  1  1  1
 20 21  1  6
 19 22  1  6
 18 23  1  1
 23 24  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 13 25  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
 28 31  1  0
 34 37  1  0
 37 38  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4475059

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 519.56

Molecular Weight (Monoisotopic): 519.2230

AlogP: 0.84

#Rotatable Bonds: 6

Polar Surface Area: 142.12

Molecular Species: NEUTRAL

HBA: 12

HBD: 3

#RO5 Violations: 2

HBA (Lipinski): 12

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 12.45

CX Basic pKa: 4.53

CX LogP: 1.45

CX LogD: 1.45

Aromatic Rings: 4

Heavy Atoms: 38

QED Weighted: 0.33

Np Likeness Score: -0.32

References

1. Crespo RA, Dang Q, Zhou NE, Guthrie LM, Snavely TC, Dong W, Loesch KA, Suzuki T, You L, Wang W, O'Malley T, Parish T, Olsen DB, Sacchettini JC..  (2019)  Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase.,  62  (9): [PMID:31002508] [10.1021/acs.jmedchem.9b00020]

Source

Source(1):

• Scientific Literature